Cover Image

Scaling up multidrug-resistant tuberculosis care in China

Saved in:

Bibliographic Details
Main Authors:	Karen R Jacobson (Author), Lora L Sabin (Author)
Format:	Book
Published:	Elsevier, 2015-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multidrug-resistant tuberculosis today
by: A Matteelli, et al.

Multidrug-resistant tuberculosis today
by: A Matteelli, et al.
Published: (2012)

Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China
by: C. Hutchison, et al.
Published: (2017)

Long term follow-up of multidrug resistant tuberculosis in a pubertal child
by: Andri Kurnia Wahyudhi, et al.
Published: (2018)

Epidemiological characteristics and risk factors of multidrug-resistant tuberculosis in Luoyang, China
by: Zhenzhen Wang, et al.
Published: (2023)

Transmission of multidrug-resistant tuberculosis in Beijing, China: An epidemiological and genomic analysis
by: Jinfeng Yin, et al.
Published: (2022)

Nomogram to predict multidrug-resistant tuberculosis
by: Saibin Wang, et al.
Published: (2020)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018)

TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATION
by: A.E. ERGESHOV, et al.
Published: (2018)

Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety
by: Jing-Tao Gao, et al.
Published: (2021)

Multidrug-resistant tuberculosis transmission among middle school students in Zhejiang Province, China
by: Yu Zhang, et al.
Published: (2020)

Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis
by: Kai Blöndal

Profile of delamanid for the treatment of multidrug-resistant tuberculosis
by: Szumowski JD, et al.
Published: (2015)

Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia
by: Fanta Desissa, et al.
Published: (2018)

The Association Between Household Financial Burden and Patient Mobility and Their Impact on Loss to Follow-Up Among Multidrug-Resistant Tuberculosis Patients in Guizhou, China
by: Wang Y, et al.
Published: (2023)

Representations on adherence to the treatment of Multidrug-Resistant Tuberculosis
by: Kuitéria Ribeiro Ferreira, et al.
Published: (2018)

Young patient with complicated multidrug-resistant tuberculosis
by: Cristóbal Gallego Muñoz, et al.
Published: (2016)

Adolescence, multidrug resistant tuberculosis, bedaquine and videotapes
by: Anna Gamell, et al.
Published: (2023)

Telemedicine in Resource-Limited Settings to Optimize Care for Multidrug-Resistant Tuberculosis
by: G. Khai Lin Huang, et al.
Published: (2019)

Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant <i>Mycobacterium tuberculosis</i> Isolates in China
by: Hongbing Jia, et al.
Published: (2021)

Rising challenge of multidrug-resistant tuberculosis in China: a predictive study using Markov modeling
by: Bing-Ying Li, et al.
Published: (2020)

Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)
by: Holly A. Taylor, et al.
Published: (2022)

Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine
by: Silvia Shinpei Chiang, et al.
Published: (2019)

Principles for designing future regimens for multidrug-resistant tuberculosis
by: Grania Brigden, et al.
Published: (2014)

Predictive model of unfavorable outcomes for multidrug-resistant tuberculosis
by: Luiz Henrique Arroyo, et al.

ANTITUBERCULOSIS DRUG ALLERGY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
by: B.B. MAYKANAEV, et al.
Published: (2021)

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis
by: N. Yu. Nikolenko, et al.
Published: (2021)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
by: Monadil H. Ali, et al.
Published: (2019)

Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study
by: Xu-Bin Zheng, et al.
Published: (2020)

Identification and attribute analysis of key stakeholders who influence multidrug-resistant tuberculosis prevention and control in China
by: Bin Chen, et al.
Published: (2021)

Multidrug-resistant tuberculosis detection and characterization of mutations in mycobacterium tuberculosis by genotype MTBDRplus
by: Rajneesh Tripathi, et al.
Published: (2017)

Main causes of chemotherapy inefficiency in patients with multidrug-resistant pulmonary tuberculosis
by: M. I. Sakhelashvili, et al.
Published: (2020)

The need to accelerate access to new drugs for multidrug-resistant tuberculosis
by: Helen S Cox, et al.
Published: (2015)

FACTORS ASSOCIATED WITH THE OCCURRENCE OF PRIMARY MULTIDRUG-RESISTANT TUBERCULOSIS IN MEDAN
by: Rizky Aditya Hutomo, et al.
Published: (2024)

Multidrug-resistant tuberculosis in India: looking back, thinking ahead
by: Anthony T Fojo, et al.
Published: (2017)

Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil
by: Marcela Bhering, et al.
Published: (2022)

New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
by: Leibert E, et al.
Published: (2014)

Prevention of multidrug-resistant tuberculosis reactivity with using innovation technologies
by: Елена Ткач, et al.
Published: (2019)

Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru
by: Dylan B. Tierney MD MPH, et al.
Published: (2016)

Clofazimine as a Treatment for Multidrug-Resistant Tuberculosis: A Review
by: Rhea Veda Nugraha, et al.
Published: (2021)